Last kr53.75 SEK
Change Today +0.50 / 0.94%
Volume 13.4K
As of 11:30 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

raysearch laboratories ab (RAYB) Snapshot

Open
kr53.75
Previous Close
kr53.25
Day High
kr53.75
Day Low
kr52.50
52 Week High
01/9/15 - kr57.00
52 Week Low
02/6/14 - kr26.70
Market Cap
1.8B
Average Volume 10 Days
21.9K
EPS TTM
kr1.49
Shares Outstanding
23.0M
EX-Date
05/28/14
P/E TM
36.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for RAYSEARCH LABORATORIES AB (RAYB)

Related News

No related news articles were found.

raysearch laboratories ab (RAYB) Related Businessweek News

No Related Businessweek News Found

raysearch laboratories ab (RAYB) Details

RaySearch Laboratories AB (publ) operates as a medical technology company that develops software solutions for enhanced radiation therapy of cancer. It offers RayStation, a treatment planning system to clinics worldwide. The company also provides RayStation installation, support, and training services. RaySearch Laboratories AB (publ) has strategic collaboration with IBA for the various treatment modalities of proton therapy; license and development agreement with Brainlab for optimizing radiation therapy; and partnership with Philips, Nucletron, and Varian. The company is headquartered in Stockholm, Sweden.

132 Employees
Last Reported Date: 11/27/14

raysearch laboratories ab (RAYB) Top Compensated Officers

Chief Executive Officer, President, Director
Total Annual Compensation: kr3.8M
Compensation as of Fiscal Year 2013.

raysearch laboratories ab (RAYB) Key Developments

CFO Anders Martin-Löf to Leave Raysearch

RaySearch Laboratories AB (publ.) announced that Anders Martin-Löf, Chief Financial Officer of RaySearch, will leave the company in April to take up the CFO post at another company. Anders will retain his responsibilities as CFO until he leaves the company. A search for Anders' successor is under way.

RaySearch Laboratories AB Enters into Long-Term Distribution Agreement with Kamol Sukosol Electric

RaySearch Laboratories AB has entered into a long-term distribution agreement with Kamol Sukosol Electric Co. The agreement means that KEC resumes full responsibility for marketing, sales and service of RaySearch's proprietary treatment planning system RayStation® on the Thai market. The agreement has already resulted in the first RayStation® order in Thailand from Lopburi Cancer Hospital in the Mueang District.

Raysearch Laboratories AB Announces Consolidated and Parent Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Raysearch Laboratories AB announced consolidated and parent earnings results for the third quarter and nine months ended September 30, 2014. For the nine months, on consolidated basis, the company reported net sales of SEK 177,435,000 against SEK 114,357,000 a year ago. Operating profit was SEK 26,593,000 against operating loss of SEK 26,127,000 a year ago. Profit before tax was SEK 26,123,000 against loss before tax of SEK 25,607,000 a year ago. Profit for the period was SEK 19,136,000 or SEK 0.56 before and after dilution against loss for the period of SEK 25,934,000 or SEK 0.76 before and after dilution a year ago. Cash flow from operating activities was SEK 27,795,000 against SEK 14,002,000 a year ago. For the quarter, on consolidated basis, the company reported net sales of SEK 71,602,000 against SEK 38,957,000 a year ago. Operating profit was SEK 18,225,000 against operating loss of SEK 15,005,000 a year ago. Profit before tax was SEK 18,057,000 against loss before tax of SEK 14,855,000 a year ago. Profit for the period was SEK 13,201,000 or SEK 0.39 before and after dilution against loss for the period of SEK 15,109,000 or SEK 0.44 before and after dilution a year ago. Cash flow from operating activities was SEK 8,761,000 against SEK 2,470,000 a year ago. Return on equity as on September 30, 2014 was 9.4%. The increase in sales and earnings was mainly attributable to higher sales of RayStation. For the nine months, on parent basis, the company reported net sales of SEK 151,759,000 against SEK 108,407,000 a year ago. Operating profit was SEK 29,302,000 against operating loss of SEK 16,844,000 a year ago. Profit before tax was SEK 28,812,000 against loss before tax of SEK 16,322,000 a year ago. Profit for the period was SEK 21,532,000 against loss for the period of SEK 16,322,000 a year ago. Cash flow from operating activities was SEK 27,795,000 against SEK 14,002,000 a year ago. For the quarter, on parent basis, the company reported net sales of SEK 61,655,000 against SEK 33,711,000 a year ago. Operating profit was SEK 20,984,000 against operating loss of SEK 11,015,000 a year ago. Profit before tax was SEK 20,812,000 against loss before tax of SEK 10,870,000 a year ago. Profit for the period was SEK 15,437,000 against loss for the period of SEK 11,882,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RAYB:SS kr53.75 SEK +0.50

RAYB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Accuray Inc $7.23 USD +0.29
Elekta AB kr88.65 SEK -0.55
Koninklijke Philips NV €24.96 EUR -0.275
Varian Medical Systems Inc $86.81 USD -0.26
View Industry Companies
 

Industry Analysis

RAYB

Industry Average

Valuation RAYB Industry Range
Price/Earnings 65.6x
Price/Sales 5.9x
Price/Book 7.5x
Price/Cash Flow 44.0x
TEV/Sales 3.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RAYSEARCH LABORATORIES AB, please visit www.raysearchlabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.